Nootropic drugs and brain cholinergic mechanisms

@article{Pepeu1989NootropicDA,
  title={Nootropic drugs and brain cholinergic mechanisms},
  author={G. Pepeu and G. Spignoli},
  journal={Progress in Neuro-Psychopharmacology and Biological Psychiatry},
  year={1989},
  volume={13},
  pages={S77-S88}
}
  • G. Pepeu, G. Spignoli
  • Published 1989
  • Psychology, Medicine
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry
1. This review has two aims: first, to marshal and discuss evidences demonstrating an interaction between nootropic drugs and brain cholinergic mechanisms; second, to define the relationship between the effects on cholinergic mechanisms and the cognitive process. 2. Direct or indirect evidences indicating an activation of cholinergic mechanisms exist for pyrrolidinone derivatives including piracetam, oxiracetam, aniracetam, pyroglutamic acid, tenilsetam and pramiracetam and for miscellaneous… Expand
Piracetam and other structurally related nootropics
Nearly three decades have now passed since the discovery of the piracetam-like nootropics, compounds which exhibit cognition-enhancing properties, but for which no commonly accepted mechanism ofExpand
A decrease in brain catecholamines prevents oxiracetam antagonism of the effects of scopolamine on memory and brain acetylcholine.
TLDR
The hypothesis that an interaction between monoaminergic and cholinergic neurotransmitter systems may be involved in the actions of nootropic drugs on cognitive functions is supported, and oxiracetam was unable to prevent both amnesia and the decrease in brain ACh levels caused by scopolamine. Expand
Overview and future directions of CNS cholinergic mechanisms.
  • G. Pepeu
  • Psychology, Medicine
  • Progress in brain research
  • 1993
TLDR
The data presented at this meeting indicate that ACh in the CNS, acting on muscarinic receptors, establishes a specific state of affairs that makes it possible for other mechanisms to work, which indicates that the central cholinergic systems have a widespread activatory function, which prepares the neurons for the information accumulation and retrieval. Expand
Aniracetam. An overview of its pharmacodynamic and pharmacokinetic properties, and a review of its therapeutic potential in senile cognitive disorders.
TLDR
Results from trials in elderly patients with mild to moderate cognitive impairment due to senile dementia of the Alzheimer type suggest that aniracetam may be of benefit, with further trials required to confirm its efficacy profile and to define more precisely those patients most likely to respond to treatment. Expand
The effects of scopolamine and the nootropic drug phenotropil on rat brain neurotransmitter receptors during testing of the conditioned passive avoidance task
We studied the effects of administration of the new nootropic drug phenotropil (N-carbamoylmethyl-4-phenyl-2-pyrrolidone) at a dose of 100 mg/kg on the quantitative characteristics of dopamine (DA),Expand
Pharmacokinetic and pharmacodynamic of the cognitive enhancer modafinil: Relevant clinical and forensic aspects
TLDR
Modafinil is a nonamphetamine nootropic drug with an increasingly therapeutic interest due to its different sites of action and behavioral effects in comparison to cocaine or amphetamine, and its psychotropic and cognitive effects are also attractive in several other pathologies and conditions that affect sleep structure, induce fatigue and lethargy, and impair cognitive abilities. Expand
Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors.
TLDR
It is proposed that the putative cognition enhancers tested may act in vivo by relieving the antagonism produced by excessive endogenous kynurenate, an endogenous glutamate receptor antagonist whose brain levels are known to increase in conditions associated to cognitive deficits. Expand
Aniracetam improves behavioural responses and facilitates signal transduction in the rat brain
TLDR
A correlation between the improvement of behavioural performance and the modulation of transducing systems by aniracetam seems to take place in brain areas, such as frontal cortex and hippocampus, known to play a major role in the control of cognitive functions. Expand
TH-9 (a theophylline derivative) induces long-lasting enhancement in excitatory synaptic transmission in the rat hippocampus that is occluded by frequency-dependent plasticity in vitro
TLDR
TH-9 may employ similar or convergent mechanisms with frequency-dependent synaptic plasticities to produce the observed long-lasting enhancement in synaptic transmission and may thus, have potential for use in improving memory. Expand
Neuronal responses mediated by activation of the non-NMDA receptors: Potentiation by nootropes
TLDR
It is supposed that nootropic drugs assist Ca2+ liberation from the neuronal depots and activate calmodulin-dependent protein kinase andprotein kinase C, which results in an increase in their sensitivity to excitatory amino acids. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 44 REFERENCES
Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine
TLDR
In conclusion, oxiracetam and anir acetam exert a stimulatory effect on specific central cholinergic pathways, however, a direct relationship between cognition-enhancing properties and Cholinergic activation needs further confirmation. Expand
The relationship between the behavioral effects of cognition-enhancing drugs and brain acetylcholine. Nootropic drugs and brain acetylcholine.
TLDR
When scopolamineinduced disruption of behavior is prevented or reduced, the scopolamininduced decrease in ACh level, particularly in the hippocampus, is also reduced, suggesting a relationship between the cognition-enhancing effects of oxiracetam and its effects on hippocampal and cortical cholinergic mechanisms. Expand
Interaction of piracetam with several neurotransmitter receptors in the central nervous system. Relative specificity for 3H-glutamate sites.
TLDR
It is concluded that effects within the glutaminergic system of the brain could contribute to the therapeutical effects of piracetam in man. Expand
Amnesic properties of scopolamine and brain acetylcholine in the rat.
TLDR
A relationship between the amnesic effect of scopolamine on recent memory and the decrease of brain ACh seems supported by these results. Expand
Effect of Oxiracetam and Piracetam on Central Cholinergic Mechanisms and Active‐Avoidance Acquisition
TLDR
It is indicated that oxiracetam enhances the activity of the septohippocampal cholinergic pathways, and to a lesser extent, of the corticalCholinergic network. Expand
Effect of pyroglutamic acid stereoisomers on ECS and scopolamine-induced memory disruption and brain acetylcholine levels in the rat.
TLDR
D,L-PCA is active on cortical and hippocampal cholinergic mechanisms and, like other 2-oxopyrrolidone derivatives, shows cognition-enhancing properties. Expand
Facilitatory effects of piracetam on excitability of motor nerve terminals and neuromuscular transmission
TLDR
The possible in vivo facilitatory effects of the pyrrolidine acetamide no-otropic agent piracetam on neuromuscular transmission, were studied based upon reports of enhancement of central cholinergic function to discuss an enhanced excitability of motor nerve terminals together with an action to increase the synthesis and/or release of acetylcholine. Expand
The effects of various cognition-enhancing drugs on in vitro rat hippocampal synaptosomal sodium dependent high affinity choline uptake.
TLDR
The results indicate that 3,4-diaminopyridine and centrophenoxine, like pramiracetam, may be increasing cognitive function in part by affecting hippocampal cholinergic neuronal activity. Expand
The effect of cholinergic drugs on [3H]acetylcholine release from slices of rat hippocampus, striatum and cortex
TLDR
Findings suggest that muscarinic receptors located on cholinergic axons or terminals have a physiological role in the autoregulation of ACh release from these 3 areas. Expand
Effects of nootropic drugs on brain cholinergic and dopaminergic transmission.
High affinity choline uptake (HACU) in the hippocampus and striatal concentration of dopamine (DA) and homovanillic acid (HVA) as measures of the in vivo acetylcholine and DA turnover, respectively,Expand
...
1
2
3
4
5
...